Cargando...
IPX066: a new intermediate-and extended-release carbidopa–levodopa formulation
Carbidopa–levodopa (CD–LD) is the mainstay of treatment for Parkinson’s disease (PD), yet most patients with advanced PD develop motor fluctuations with time when treated with CD–LD. Development of longer-acting CD–LD formulations is a major goal for reducing motor fluctuations in advanced PD. IPX06...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3910659/ https://ncbi.nlm.nih.gov/pubmed/24501594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.13.4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|